After the CDC approved immunizations for children aged 6 months to 5 years, 4-year-old Eleanor Kahn sat with dad Alex, as nurse Jillian Mercer vaccinated Moderna for coronavirus disease (COVID-19) at Rady Children’s Hospital in San Diego, California, USA, June 21, 2022.
Mike Blake | Reuters
Moderna The company has asked the Food and Drug Administration for permission to inject omicron supplements for children, the company announced Friday.
Moderna has filed two separate FDA authorization requests, one for teens ages 12 to 17 and another for kids ages 6 to 11. The Boston biotech company said it also would ask the FDA to remove the shots for the youngest children, 6 months to 5 years old. -is, the end of this year.
The Centers for Disease Control and Prevention, in a document released Tuesday, said it expects children to be eligible for the omicron-enhancing drug by mid-October pending FDA approval. The CDC’s Vaccine Advisory Committee has meetings scheduled for October 19 and 20.
Pfizer told the CDC advisory committee earlier this month that it expected to ask the FDA to authorize the drug to raise omicrons for children ages 5 to 11 by early October.
US Health Administration removed Moderna’s omicron boosters for adults in the first day of this month. Pfizer boosters are allowed for people 12 years of age and older.
The new injections target the omicron differential strain BA.5 as well as the original strain of Covid that first appeared in China in late 2019. The FDA and CDC hope the new boosters will provide protection. provide superior protection against infection and disease because they target the most common secondary omicrons.
Older vaccines, designed to fight the original Covid strain, no longer provide meaningful protection against infection and mild illness because the virus has mutated so much. There is also concern that the effectiveness of the initial shots in preventing hospitalization and serious illness is beginning to decrease.
Public health officials have confidence in the new omicron BA.5 boosters, though their effectiveness in the real world remains unclear. Injections allowed without data from human clinical trials